EA201201281A1 - Обогащение диеты матерей сиаловой кислотой - Google Patents

Обогащение диеты матерей сиаловой кислотой

Info

Publication number
EA201201281A1
EA201201281A1 EA201201281A EA201201281A EA201201281A1 EA 201201281 A1 EA201201281 A1 EA 201201281A1 EA 201201281 A EA201201281 A EA 201201281A EA 201201281 A EA201201281 A EA 201201281A EA 201201281 A1 EA201201281 A1 EA 201201281A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mothers
diets
enhancement
sialic acid
sial acid
Prior art date
Application number
EA201201281A
Other languages
English (en)
Other versions
EA025117B1 (ru
Inventor
Джон Пол Циммер
Кристофер Майкл Бат
Original Assignee
ДСМ АйПи АССЕТС Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44563861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201201281(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ДСМ АйПи АССЕТС Б.В. filed Critical ДСМ АйПи АССЕТС Б.В.
Publication of EA201201281A1 publication Critical patent/EA201201281A1/ru
Publication of EA025117B1 publication Critical patent/EA025117B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

В изобретении предлагаются способы и композиции для улучшения здоровья и развития плода и ребенка посредством обогащения пищи, например, сиаловой кислотой. Сиаловая кислота может вводиться женщине перед, в течение и/или после беременности для улучшения здоровья и развития плода и/или ребенка. Сиаловая кислота может быть представлена добавками во множестве форм.
EA201201281A 2010-03-12 2011-03-11 Способ улучшения развития нервной системы и/или мозга плода или ребёнка, находящегося на грудном вскармливании EA025117B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31363010P 2010-03-12 2010-03-12
PCT/US2011/028068 WO2011112913A1 (en) 2010-03-12 2011-03-11 Maternal sialic acid supplementation

Publications (2)

Publication Number Publication Date
EA201201281A1 true EA201201281A1 (ru) 2013-10-30
EA025117B1 EA025117B1 (ru) 2016-11-30

Family

ID=44563861

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201201281A EA025117B1 (ru) 2010-03-12 2011-03-11 Способ улучшения развития нервной системы и/или мозга плода или ребёнка, находящегося на грудном вскармливании

Country Status (18)

Country Link
US (2) US8703716B2 (ru)
EP (1) EP2544539B1 (ru)
JP (1) JP6028264B2 (ru)
KR (1) KR101910203B1 (ru)
CN (2) CN104687046A (ru)
AU (1) AU2011224220C1 (ru)
BR (1) BR112012023004A2 (ru)
CA (1) CA2792112C (ru)
EA (1) EA025117B1 (ru)
ES (1) ES2540994T3 (ru)
HK (1) HK1209000A1 (ru)
MX (1) MX2012010533A (ru)
MY (1) MY160679A (ru)
NZ (1) NZ602370A (ru)
PL (1) PL2544539T3 (ru)
SG (2) SG183978A1 (ru)
WO (1) WO2011112913A1 (ru)
ZA (1) ZA201206801B (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2772955C2 (ru) * 2015-12-15 2022-05-27 Сосьете Де Продюи Нестле С.А. Смесь олигосахаридов человеческого грудного молока
US11957148B2 (en) 2015-12-15 2024-04-16 Societe Des Produits Nestle S.A. Mixture of human milk oligosaccharides(HMOs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016053309A1 (en) 2014-09-30 2016-04-07 Kimberly-Clark Worldwide, Inc. Creped prebiotic tissue
KR20170065540A (ko) 2014-09-30 2017-06-13 킴벌리-클라크 월드와이드, 인크. 상승적 프리바이오틱 조성물
WO2016086128A1 (en) 2014-11-25 2016-06-02 Abbott Laboratories Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
CN104757460A (zh) * 2015-04-10 2015-07-08 广西大学 一种赤豆南瓜胡萝卜保健营养粉及其制作方法
CN104738647A (zh) * 2015-04-10 2015-07-01 广西大学 一种白扁豆土豆菠萝保健营养粉及其制作方法
CN104856059A (zh) * 2015-06-03 2015-08-26 广西大学 一种减肥的保健营养粉
CN104996986A (zh) * 2015-07-10 2015-10-28 武汉中科光谷绿色生物技术有限公司 大肠杆菌发酵来源的n-乙酰神经氨酸在食品中的应用
CN108367025A (zh) * 2016-03-30 2018-08-03 雀巢产品技术援助有限公司 包含矿物质的组合物及其用途
WO2018020473A1 (en) 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Dairy product and process
JP6762027B2 (ja) * 2016-08-25 2020-09-30 株式会社雅嘉貿易 シアロオリゴ糖の製造方法とその利用
CN106723051A (zh) * 2017-01-20 2017-05-31 西宝生物科技（上海）股份有限公司 一种益智健脑组合物及其制备方法
WO2020049561A1 (en) * 2018-09-04 2020-03-12 Milkstrip Ltd. A method for testing body fluids
WO2020128876A1 (en) 2018-12-19 2020-06-25 Presinus Pharmaceuticals Private Limited Composition comprising iodine; selenium, vitamin d3 and lycopene for the prevention and treatment of hypothyroidism
SG10201900604TA (en) * 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Pre-natal beta-cryptoxanthin benefits children
WO2020259540A1 (zh) * 2019-06-25 2020-12-30 嘉必优生物技术（武汉）股份有限公司 唾液酸类化合物在制备治疗脑部退行性病变药物或营养添加剂或食品中的应用
CN113424964B (zh) * 2021-06-17 2022-05-27 汤臣倍健股份有限公司 一种组合物在制备调节人乳营养和免疫成分的保健食品或食品中的应用
WO2023049853A1 (en) * 2021-09-23 2023-03-30 The Regents Of The University Of California Promoting myelination by n-acetylglucosamine and modulation of n-glycan branching

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4044630B2 (ja) * 1996-05-16 2008-02-06 雪印乳業株式会社 脳機能改善剤
JP2997419B2 (ja) * 1996-05-31 2000-01-11 雪印乳業株式会社 脳ガングリオシド含量減少抑制剤
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
WO2005000040A1 (en) * 2003-06-24 2005-01-06 University Of Kansas Medical Center Infant formula
CN1701789A (zh) * 2005-05-13 2005-11-30 韩孝清 含有唾液酸及其衍生物的营养补充剂
CA2556343A1 (en) * 2005-09-01 2007-03-01 Purepharm Inc. Synthetic nutritional formulations
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
WO2008150477A2 (en) * 2007-05-31 2008-12-11 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine as a therapeutic agent
CA2702570A1 (en) * 2007-10-19 2009-04-23 Christopher Paul Mcjarrow Methods of maintaining or increasing growth or cognitive development
EP2096115A1 (en) 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
EP2110027A1 (en) 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2116139A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support brain health in the elderly
JPWO2009144977A1 (ja) * 2008-05-28 2011-10-06 研二 岡嶋 経口育毛用組成物
US20110053889A1 (en) 2008-09-02 2011-03-03 Joanne Szabo Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function
DK2183984T3 (da) 2008-11-10 2012-04-02 Nestec Sa Sialsyreproducerende bakterier

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2772955C2 (ru) * 2015-12-15 2022-05-27 Сосьете Де Продюи Нестле С.А. Смесь олигосахаридов человеческого грудного молока
US11957148B2 (en) 2015-12-15 2024-04-16 Societe Des Produits Nestle S.A. Mixture of human milk oligosaccharides(HMOs)

Also Published As

Publication number Publication date
EP2544539B1 (en) 2015-04-29
US20130137643A1 (en) 2013-05-30
AU2011224220C1 (en) 2016-03-10
HK1209000A1 (en) 2016-03-24
AU2011224220B2 (en) 2014-10-23
MY160679A (en) 2017-03-15
CA2792112C (en) 2018-09-04
MX2012010533A (es) 2013-02-11
JP6028264B2 (ja) 2016-11-16
KR101910203B1 (ko) 2018-10-19
SG183978A1 (en) 2012-10-30
US20140080767A1 (en) 2014-03-20
PL2544539T3 (pl) 2015-10-30
CN102946728B (zh) 2015-09-23
ES2540994T3 (es) 2015-07-15
JP2013522234A (ja) 2013-06-13
WO2011112913A1 (en) 2011-09-15
CN102946728A (zh) 2013-02-27
SG10201500853TA (en) 2015-04-29
EP2544539A4 (en) 2013-07-31
AU2011224220A1 (en) 2012-10-04
EP2544539A1 (en) 2013-01-16
BR112012023004A2 (pt) 2015-09-15
CA2792112A1 (en) 2011-09-15
NZ602370A (en) 2014-11-28
CN104687046A (zh) 2015-06-10
US8703716B2 (en) 2014-04-22
EA025117B1 (ru) 2016-11-30
KR20130008581A (ko) 2013-01-22
ZA201206801B (en) 2014-03-26

Similar Documents

Publication Publication Date Title
EA201201281A1 (ru) Обогащение диеты матерей сиаловой кислотой
MY166016A (en) Infant nutrition for improving fatty acid composition of brain membranes
MX2013010831A (es) Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga.
BR112013016929A2 (pt) oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
EA201690652A1 (ru) Высокобелковая композиция денатурированного сывороточного белка, связанные с ней продукты, способ их получения и применения
NZ631404A (en) Fermented infant formula with non digestible oligosaccharides
BR112013024199A2 (pt) métodos para melhorar a saúde óssea em bebês usando prebióticos
IN2012DN00486A (ru)
MY175195A (en) Nutritional compositions
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2011012297A (es) Mejoramiento de la salud gastrointestinal, la inmunidad y el rendimiento mediante intervención dietética.
BR112015005933A2 (pt) composição nutricional para mulher grávida com um perfil benéfico de glicose e insulina
MX2016000187A (es) Composiciones y metodos para mejorar el rendimiento del ejercicio.
MX2017009929A (es) Composiciones y métodos para metabolismo muscular mejorado.
BR112012033064A2 (pt) programação precoce de função cerebral através de alimentação com proteína de soja
BR112015024323A2 (pt) composição nutricional compreendendo soro de leite e caseína hidrolisada e usos da mesma
IN2015DN02772A (ru)
PH12014501782B1 (en) Maternal supplement to enhance immune system of an infant
MX2018005881A (es) Suplemento dietético que comprende beta-glucano e hidrolizado de caseína para mejorar la salud y el desempeño del crecimiento de un mamifero.
CN103652590A (zh) 一种提高免疫力的辅食
TH142624A (th) อาหารเสริมสำหรับมารดาที่มีกรดซิอาลิก
CN103585092A (zh) 一种深层去角质修复乳
TH121222B (th) ของผสมของโอลิโกแซ็กคาไรด์ชนิดไม่สามารถย่อยได้สำหรับการกระตุ้นระบบภูมิคุ้มกัน
WO2015026708A3 (en) Amelioration of the effects of friedriech's ataxia
UA68764U (ru) Способ улучшения сократительной функции матки коров мясных пород

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM